Engineering a Nanostructured Nucleolin-Binding Peptide for Intracellular Drug Delivery in Triple-Negative Breast Cancer Stem Cells
Mireia Pesarrodona(Universitat Autònoma de Barcelona), Esther Vázquez, Simó Schwartz(CIBBIM-Nanomedicine), Joaquin Seras‐Franzoso(Vall d'Hebron Institut de Recerca), José Juan Jara(Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine), Antonio Villaverde(Universitat Autònoma de Barcelona), Patricia Cámara‐Sánchez(Universitat Autònoma de Barcelona), Naroa Serna(Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine), Ibane Abasolo(Unknown), Petra Gener(CIBBIM-Nanomedicine), Míriam Royo(Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine), Ricardo Baltà‐Foix(Universitat Autònoma de Barcelona), Daniel Pulido(Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine), Laura Sánchez‐García(Universidade de Santiago de Compostela), Alejandro Sánchez‐Chardi(Universitat Autònoma de Barcelona)
Cited by 24
Related Papers
Bacterial Inclusion Bodies: Discovering Their Better Half
|Trends in Biochemical Sciences|2017|181
Bacterial inclusion bodies: making gold from waste
|Trends in biotechnology|2011|173
Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes
|Microbial Cell Factories|2015|147
Fluorescent CSC models evidence that targeted nanomedicines improve treatment sensitivity of breast and colon cancer stem cells
|Nanomedicine Nanotechnology Biology and Medicine|2015|85
Perspectives of nano-carrier drug delivery systems to overcome cancer drug resistance in the clinics
|Cancer Drug Resistance|2021|85